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Summary-Prostate cancer is currently the most commonly diagnosed cancer among males in the 
United States. As technology improves and the search for this enigmatic condition intensifies, we 
are detecting greater numbers of non-palpable tumours. These tumours are generally treated 
aggressively, given the uncertainty of their behaviour, but this approach may be over-zealous for 
small volume disease. The likelihood of detecting any cancer volume can be derived from Bayes' 
theorem of conditional probability. A laboratory model using coloured clay was created to contrast 
tumour volumes of 2.5,5 and 20% (n = 75). Six random systematic biopsies were then taken from 
each model in a blind fashion; 36% of the 2.5%, 44% of the 5% and all of the 20% models had at 
least 1 positive biopsy. Twenty-two of the 25  models representing 20% tumour had 3 or more 
biopsy cores positive. These data suggest that low volume disease with low biological potential will 
be found by random biopsy as  the mathematical probability predicts. The high incidence of occult 
prostate cancer in the older population makes this a worrying observation. Also, and perhaps more 
important, there is a direct correlation between the volume of disease and the number of positive 
biopsies. This correlation is easily seen in both models and may allow for an  estimation of tumour 
volume. This ability to estimate tumour volume may be a useful clinical tool that helps to guide 
therapy and assess prognosis. 
Prostatic cancer is now the most common clinically 
diagnosed cancer among males in the United States 
(Optenberg and Thompson, 1990). This increased 
rate of detection is due in part to widespread 
screening, which has uncovered more early stage 
and non-palpable cancer. In 1981, Cantrell et al. 
described A1 disease as 15% cancer by volume 
with a Gleason score of 1 4  (Cantrell et al., 1981). 
Of those individuals whose prostate glands had < 
5% cancer only 2% showed progression. None of 
their well differentiated tumours advanced and only 
11% (5/47) of those with Gleason scores 5 or 6 
progressed. This study reaffirmed that stage A 
prostate cancer generally behaves in a benign 
manner provided it is not high grade and, together 
withother studies, supports the expectant treatment 
of individuals with low volume/grade carcinoma 
found on transurethral resection of the prostate 
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(TURP). This management is justified since the 15- 
year survival with A1 disease is similar to that of 
age-matched controls (Hanash et al., 1972). Those 
individuals with A2 (high volume or high grade) 
disease, however, are generally directed towards 
aggressive therapy. 
Given increased public awareness and the inten- 
sified search, smaller volumes of cancer are being 
found which would previously have remained 
undetected. Nevertheless, patients with any cancer 
whatsoever found on needle biopsy are, seemingly 
by reflex, treated in an aggressive manner. The 
apparent basis for this practice is the belief that A1 
disease is unlikely to be detected by needle biopsy 
and the inability to distinguish it from A2 disease 
pre-operatively . 
Given these unknowns, we have attempted to 
determine the incidence of a positive needle biopsy 
for a series of known cancer volume relationships. 
A mathematical model based on Bayesian statistics 
of conditional probability was used to derive 
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diagnostic probabilities. A laboratory model was 
then created to contrast volumes of 2.5% and 5% 
cancer representing stage A1 disease, witha volume 
of 20% cancer representing stage A2 disease. 
as positive if any amount of the cancer colour could 
be detected by visual inspection. A cross-sectioned 
clay model “prostate” is shown in Figure 1. 
Materials and Methods 
Mathematical probability was used to determine 
the likelihood of detecting cancer for any number 
of biopsies. This relationship is Bayes’ theorem of 
conditional probability, which is a derivative of the 
binomial theorem (Woolson, 1981): 
Pr(S+/C+)=l-(1 -p)” 
where Pr(S + /C +) represents the probability that 
the sequence of biopsies is positive given that the 
patient has cancer, p stands for the volume percent 
of the prostate that is malignant and n represents 
the number of biopsies in the sequence. The 
sequence is defined as positive if any one or more 
of the biopsies in the sequence is positive. This 
classic model deals with whole numbers and is valid 
if 2 assumptions are met: both the distribution of 
cancer and the biopsies must be random. While we 
are aware that no clinical event is ever truly 
random, the known multifocal nature of prostate 
carcinoma allows it to be considered as such for 
practical purposes. The method of “systematic 
random” biopsy is also not mathematically random 
but the inherent technical variability therein further 
supports this assumption. 
The laboratory model was created from contrast- 
ing colours of clay: one designated as normal 
prostate tissue and the other as carcinoma. The 
normal tissue clay was sectioned into 39, 38 and 
32 ml volumes and the clay designated as malignant 
was measured into 1, 2 and 8 ml volumes. These 3 
groups of 25 each represented cancer volumes of 
2.5, 5.0 and 20% respectively. The cancer clay was 
divided into 6 various sized foci and the prostate 
clay was broken into similar size pieces. Both were 
placed in airtight bags to ensure the volume would 
not change as a result of moisture loss. They were 
then placed in a freezer for 24 to 48 h, which 
allowed for more even mixing. Their contents were 
placed in a bowl and stirred with an electric hand 
mixer for approximately 1 min. The clay particles 
were then emptied into a small container and 
blindly packed roughly into the shape of a prostate. 
These “prostates” were then wrapped in aluminum 
foil and put back in the freezer for another 24 to 
48 h. Six random systematic biopsies were subse- 
quently taken, from the apex to the base, as 
described by Hodge et al. (1989). A biopsy was read 
Results 
The results from calculating Bayes’ theorem with 
the number of biopsies (n)= 1-6 and the percent 
cancer (p)=1-5%, lo%, 20%, 25% and 50% are 
indicated in Table 1. The calculations show that as 
the number of biopsies or the percent volume 
cancer increases, so does the probability of finding 
positive histology. The mathematical model pre- 
dicts that 26.5% of glands with 5% cancer will have 
at least 1 of 6 positive biopsies. Even if only 4 are 
taken, almost 20% will show cancer. 
Of the 25 clay prostates with 2.5% cancer, 9 had 
a positive biopsy, all of these showing only 1 of the 
6 biopsies to be positive. In other words, of the 150 
Fig. 1 A cross-sectioned model prostate. 
Table 1 
From Bayes’ Theorem 












No. of biopsies 
I 2 3 4 5 6 
0.010 0.020 0.030 0.039 0.049 0.059 
0.020 0.040 0.059 0.078 0.096 0.114 
0.030 0.059 0.087 0.115 0.141 0.167 
0.040 0.078 0.115 0.151 0.185 0.217 
0.050 0.098 0.143 0.185 0.226 0.265 
0.100 0.190 0.271 0.344 0.410 0.469 
0.200 0.360 0.488 0.590 0.672 0.738 
0.250 0.438 0.578 0.684 0.763 0.822 
0.500 0.750 0.875 0.938 0.969 0.984 
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Table 2 Laboratory Model Results 
No. of Percent volume cancer 
positive 
biopsies 2.5% 5.0% 20.0% 
0 16 14 
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cores taken, only 6% were positive. Eleven or 44% 
of the 5% cancer model had at least 1 positive 
biopsy. Here, only 2 “prostates” had more than 1 
positive biopsy and none had as many as 3.  For this 
volume (5%) the total number of positive biopsies 
was 13 or 8.7%. 
In the 20% volume cancer group used to illustrate 
A2 disease, all of the prostates had at least 2 
biopsies positive; 22 of these had 3 or more positive. 
A total of 85 of the 150 (56.7%) taken demonstrated 
the cancer colour. These results are shown in 
Table 2. 
Discussion 
The stimulus for this work arose from our growing 
concern over the increasing effort directed towards 
the detection of non-palpable prostate cancer. Since 
much non-palpable disease is low volume and has 
a good prognosis, aggressive treatment may not be 
appropriate (George, 1988 ; Johansson et al., 1989; 
Adolfsson et al., 1990; Graversen et al., 1990; 
Adolfsson and Carstensen, 1991). With more 
screening modalities and an intensified search, the 
rate of detection of smaller, clinically insignificant 
tumours is most likely to be affected. While both 
prostate specific antigen (PSA) and prostate ultra- 
sound have many drawbacks in screening for 
carcinoma of the prostate, they often do lead to 
prostate biopsy (Hudson et al., 1989; Terris et al., 
1991). If a biopsy then demonstrates carcinoma, it 
is presumed that the histology is the cause for the 
abnormal test. However, it is possible that the 2 
events are unrelated and that the positive biopsy 
simply reflects the prevalence of the condition in 
the population. Step sections of prostates without 
evidence of clinical disease on examination from 
autopsy and radical cystectomy specimens have 
found prostate carcinoma in 30 to 40% of older men 
(McNeal, 1969; Montie et al., 1989). Most of these 
specimens showed low volume disease. Both the 
mathematical and laboratory model described 
herein demonstrate that low volume disease will be 
found in sizeable numbers by random biopsy. 
The results obtained from the clay models parallel 
those derived from Bayes’ theorem (Fig. 2). The 
consistently higher rate of detection from the clay 
model probably reflects simply the vagaries of small 
numbers. Regardless of the model used, it appears 
that low volume disease can be detected by random 
biopsy. In fact, cancer was found in 36% of the 
model with 2.5% cancer. Given the high prevalence 
of occult disease in the older population, these 
numbers are alarming. There is an enormous 
number of men in whom our current practice 
pattern will allow us to detect clinically insignificant 
adenocarcinoma. More challenging is the task of 
determining what therapy, if any, is best suited for 
these individuals. This work suggests that multiple 
random biopses may be helpful in estimating 
tumour volume, thus guiding therapeutic decisions 
recalling the behaviour of small volume disease 
found on TURP. 
Gleasonscore can differentiate A1 and A2 disease 
with ample needle biopsy. A poorly differentiated 
biopsy makes the lesion at least A2 regardless of 
volume. Conversely, low grade histology is associ- 
ated with low volume disease (Catalona and Scott, 
1986). Further information regarding volume of 
disease can be provided by analysing the number of 
positive biopsies; 88% of the A2 model (20%) had 
at least 3 positive biopsies, while none of the 50 
models representing A1 disease showed more than 
2 positive and only 2 of 50 had more than 1 positive. 
Recently, in an attempt to determine the ability 
of systematic biopsy to detect cancer in men with 
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Fig. 2 Comparison of predicted calculated versus measured 
positive biopsies. 
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BPH, Coplen et al. (1991) also found small volume 
disease using multiple biopsies. We believe the 
finding of well differentiated carcinoma in 1 of 6 
cores may well represent stage A1 disease as shown 
in their report. It may be appropriate for a healthy 
50-year-old in this situation to be treated vigorously 
but an older individual may best be served by close 
follow-up, as are those with A1 disease found by 
transurethral resection. Conversely, a patient with 
5 or 6 positive biopsies almost certainly has large 
volume disease and requires therapy. We believe 
multiple random biopsies must be done judiciously, 
and in the proper setting will provide the clinician 
with useful data to buffer the uncertainties in 
dealing with this enigmatic disease. 
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